Registration NO:鄂械注准20242405154
NGAL is an early biomarker for detecting kidney disease, especially acute kidney injury (AKI). Used for auxiliary diagnosis of renal tubular injury.
【Clinical significance】
NGAL is an early biomarker for detecting kidney disease, especially acute kidney injury (AKI). Used for auxiliary diagnosis of renal tubular injury.【Application scenarios】
Community hospitals, third-party medical institutions, nephrology departments, emergency departments, and intensive care units.
【Positive judgment value】
When the NGAL content in the sample is greater than 100ng/mL, it is considered positive.
【Intended Use】
This product is used for in vitro qualitative detection of neutrophil gelatinase related lipocalin in human urine.
【Product registration certificate number】
鄂械注准20242405154
【Manufacturing Enterprise 】
Wuhan Xurui Biotechnology Co., Ltd
